Democratic attorneys general file lawsuit against FDA over abortion pill regulations
Agency hits abortion medication with “unique” set of rules, suit alleges.
The Facts Inside Our Reporter’s Notebook
A group of Democratic attorneys general filed suit against the U.S. Food and Drug Administration on Friday over the agency’s regulation of abortion medication.
The lawsuit, filed in U.S. district court in Washington State, claims that the FDA “hamper access” to the abortion-causing drug mifepristone by “singling [it] out … for a unique set of restrictions.”
The restriction in question is called “Risk Evaluation and Mitigation Strategy;” the FDA on its website says that system is applied to “certain medications with serious safety concerns to help ensure the benefits of the medication outweigh its risks."
In their lawsuit the attorneys general claim that mifepristone “has been on the market for more than two decades with only ‘exceedingly rare’ adverse events.”
The suit demands that the court force the FDA to remove its REMS regulation of mifepristone, which the prosecutors claim is a “safe, proven drug that is a core element of reproductive health care.
Just News, No Noise
- Joe Biden bribery allegations involve Ukraine, first raised with FBI in 2017, key investigator says
- Christian man arrested for quoting Bible verse at pride event
- Matt Gaetz introduces resolution to hold former Trump probe prosecutor Mark Pomerantz in contempt
- J6 Unmasked: Security footage confirms Capitol door opened, allowing 300 to enter building freely
- FBI harbored Biden allegations since 2017, through impeachment, election, lawmaker says